Active substance
Ascorbic acid
- SFDA 12
- US FDA 4
- Health Canada 3
- NHS prices 4
- WHO EML 1
- Safety 8
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| CEVITIL 1 g effervescent tablet | 1 g | Effervescent tablet · Oral use | 12 Tablet Container | SAR 5.10 | Generic · OTC | EIPICO | Valid |
| C-VITAL 1G EFFERVESCENT TABLETS SUGAR FREE | 1 g | Effervescent tablet · Oral use | 20 Tablet Container | SAR 7.30 | Generic · OTC | PHARMALINE | Invalid · Not Marketed |
| CEBION DROPS | 100 mg/ml | Oral drops, solution · Oral use | 1 Dropper Container | SAR 6.90 | NCE · OTC | Merck Healthcare KGaA | Withdrawn by MAH · Not Marketed |
| CEBION EFFRV | 1 g | Effervescent tablet · Oral use | 10 Tablet Container | SAR 7.25 | NCE · OTC | Merck Healthcare KGaA | Withdrawn by MAH · Not Marketed |
| CEVILENE DROPS | 100 mg/ml | Oral drops, solution · Oral use | 1 Dropper Container | SAR 3.60 | Generic · OTC | KAHIRA EYGEPT | Withdrawn by regulatory authority · Not Marketed |
| CEVITAN EFFERVESCENT TAB | 1 g | Effervescent tablet · Oral use | 10 Tablet Container | SAR 6.05 | Generic · OTC | SOBARA | Invalid · Not Marketed |
| JOSWE C 100MG EFFERVESCENT TABLETS | 100 mg | Effervescent tablet · Oral use | 10 Tablet Container | SAR 4.15 | Generic · OTC | Jordan Sweden Medical and Sterilization Co. | Withdrawn by MAH · Not Marketed |
| REDOXON EFFERVESCENT TAB | 1 g | Effervescent tablet · Oral use | 10 Tablet Container | SAR 9.45 | Generic · OTC | BAYER CONSUMER CARE AG | Withdrawn by MAH · Not Marketed |
| REDOXON EFFERVESCENT TAB | 1 g | Effervescent tablet · Oral use | 15 Tablet Container | SAR 14.15 | Generic · OTC | BAYER CONSUMER CARE AG | Withdrawn by MAH · Not Marketed |
| REDOXON EFFERVESCENT TAB | 1 g | Effervescent tablet · Oral use | 10 Tablet Container | SAR 9.45 | Generic · OTC | BAYER SANTE FAMILIALE | Withdrawn by MAH · Not Marketed |
| UPSA-C EFFERVESCENT TAB 1GM | 1 g | Effervescent tablet · Oral use | 10 Tablet Container | SAR 5.80 | Generic · OTC | UPSA | Withdrawn by MAH · Not Marketed |
| VIFORCIT EFFERVESCENT TABLET | 1 g | Effervescent tablet · Oral use | 10 Tablet Container | SAR 4.60 | Generic · OTC | UNIVERSAL PHARMACEUTICAL INDUSTRIES (UNIPHARMA) | Suspended · Not Marketed |
Indications — CHI Daman Drug Formulary
MUCOSAL ULCERATION-SUPPORTIVE AGENTS
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| ASCOR | 25,000MG/50ML (500MG/ML) | solution · intravenous | MCGUFF | Prescription | 2 Oct 2017 |
| ASCORBIC ACID | 25,000MG/50ML (500MG/ML) | solution · intravenous | FRESENIUS KABI USA | Prescription | 7 Aug 2025 |
| ASCORBIC ACID | 25,000MG/50ML (500MG/ML) | solution · intravenous | STIRA | Prescription | 30 Jul 2026 |
| ASCORBIC ACID | 2,500MG/5ML (500MG/ML); 5,000MG/10ML (500MG/ML); 25,000MG/50ML (500MG/ML) | solution · intravenous | ZYDUS PHARMS | Prescription | 20 Aug 2026 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| ASCOR L 500 | 02355981 | 500 MG / ML | SOLUTION · INTRAVENOUS; SUBCUTANEOUS; INTRAMUSCULAR | MCGUFF PHARMACEUTICALS INC |
| VITAMIN C | 00780634 | 250 MG / ML | LIQUID · INTRAMUSCULAR; INTRAVENOUS | SANDOZ CANADA INCORPORATED |
| VITAMIN C | 02245214 | 500 MG / ML | SOLUTION · SUBCUTANEOUS; INTRAMUSCULAR; INTRAVENOUS | MYLAN PHARMACEUTICALS ULC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| NHS Drug Tariff | Ascorbic acid 100mg tablets | £97.19 | 28 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Ascorbic acid 200mg tablets | £134.09 | 28 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Ascorbic acid 500mg tablets | £58.48 | 28 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Ascorbic acid 50mg tablets | £105.75 | 28 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
WHO WHO Model List of Essential Medicines (2025)
- 27. Vitamins and minerals · core
Scurvy
Oral > Solid: 50 mg
Safety signals and safety-related labeling changes
- US FDA 6 Nov 2024 INFUVITE ADULT — safety-related labeling change
Labeling sections changed: Use in Specific Populations - US FDA 6 Nov 2024 INFUVITE PEDIATRIC — safety-related labeling change
Labeling sections changed: Use in Specific Populations - US FDA 8 Sep 2023 PLENVU — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Patient Counseling Information / Patient Information / Medication Guide - US FDA 8 Jul 2022 ASCOR — safety-related labeling change
Labeling sections changed: Warnings and Precautions - US FDA 6 Apr 2022 MOVIPREP — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions; Drug Interactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - US FDA 16 Dec 2020 M.V.I. ADULT — safety-related labeling change
Labeling sections changed: Contraindications; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - US FDA 9 Nov 2017 M.V.I. ADULT (PHARMACY BULK PACKAGE) — safety-related labeling change
Labeling sections changed: Contraindications; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - US FDA 9 Nov 2017 M.V.I.-12 — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide
Combinations containing Ascorbic acid
- Acetylsalicylic acid + ascorbic acid
- Ascorbic acid + calcium carbonate
- Ascorbic acid + calcium glycerophosphate
- Ascorbic acid + ferrous sulfate
- Ascorbic acid + paracetamol
- Ascorbic acid + sodium ascorbate
- Ascorbic acid + vitamin b complex
- Ascorbic acid + calcium carbonate + calcium lactate gluconate
- Ascorbic acid + calcium carbonate + effervescent base
- Ascorbic acid + lysozyme + vitamin k
- Ascorbic acid + paracetamol + phenylephrine
- Ascorbic acid + tocopherol + vitamin b complex
- Ascorbic acid + calcium carbonate + colecalciferol + pyridoxine
- Ascorbic acid + calcium carbonate + vitamin b6 + vitamin d3
- Ascorbic acid + cyanocobalamin + folic acid + nicotinamide
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.